AP-1 is involved in a wide range of physiological and pathological functions[11], and many previous studies have demonstrated that AP-1 activity dysregulation contributes to tumorigenesis, tumor progression, aggressiveness and resistance to therapy [12,13] . Here, JUNB is linked to neoplasm.